Openbookopenbook
Equity
STE
+0.0 · +0.00%
USD · NYSE

STERIS plc(STE) Stock Analysis | Healthcare

USD --+0.00%
Reward63Moderate
Risk31Moderate
75%Data
Quality Compounder
Market Cap:22.79Bn
ⓘ
Reward Rating
63
Moderate
Reward Assessment
75% data coverage
Top 50% of stocksView factors
ⓘ
Risk Rating
31
Moderate
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on STE to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for STE, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $263.13.

What is STERIS plc?

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.

STE · Verdict

Solid reward · moderate risk

STE scores well on cash flow and balance sheet with no major weaknesses flagged in the model.

Based on 88% data coverage

STE · Verdict

What’s working & what to watch

Strengths 4

  • Cash flow89/100

    16% free-cash-flow margin

  • Balance sheet83/100

    Interest covered 18.3×

  • Growth71/100

    Rev +9.4% CAGR · earnings +94.3%

  • Profitability70/100

    13% net margin · 11% ROE

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is STERIS plc?

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 22.79B, and a P/E ratio of 28.6x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (63)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

PHGLarge Cap / 26.8B market cap
Koninklijke Philips NV ADR
Compare
ZBHLarge Cap / 19.3B market cap
Zimmer Biomet Holdings Inc
Compare
RYLPFLarge Cap / 31B market cap
Koninklijke Philips N.V
Compare
Company Information
SectorHealthcare
IndustryMedical Devices
Market Cap22.79B
P/E Ratio28.5795
Dividend Yield1.08%
Beta0.914
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
13,098 shares
$735k
0
6-9months
0
0
9-12months
425,203 shares
$6.6M
0
9 disclosures without share count
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.